Medicare Will Not Fully Cover Aduhelm, the Controversial?and Costly?Alzheimer's Disease Drug
Companies, agencies, institutions, etc
Medicare
the Centers for Medicare
Medicaid Services
Biogen
Aduhelm
the Food and Drug Administration
Health and Human Services
People
Xavier Becerra
Groups
No matching tags
Physical locations
No matching tags
Places
No matching tags
Locations
No matching tags
Events
No matching tags
Summary
On Jan. 11, Medicare and Medicaid said it will limit coverage for Aduhelm, the expensive and controversial Alzheimer's drug from Biogen.
As said here by RICARDO ALONSO-ZALDIVAR / AP